Article Information
History
- April 27, 2018.
Article Versions
- Version 1 (April 6, 2018 - 14:02).
- Version 2 (April 17, 2018 - 09:26).
- You are currently viewing Version 3 of this article (April 27, 2018 - 10:36).
- Version 4 (September 17, 2018 - 13:52).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andres Colubri1,4,5,
- Adam C. Levine2,3,
- Mathew Siakor3,
- Vanessa Wolfman3,
- Mary-Anne Hartley7,8,
- Tom Sesay9,
- August Felix4 and
- Pardis C. Sabeti1,4,5,6
- 1Harvard University, Department of Organismic and Evolutionary Biology, Cambridge, MA, USA
- 2Brown University, Warren Alpert School of Medicine. Providence, RI, USA
- 3International Medical Corps. Los Angeles, CA, USA
- 4Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 5Howard Hughes Medical Institute, Chevy Chase, MD, USA
- 6Harvard School of Public Health, Boston, MA, USA
- 7University of Lausanne, Faculty of Biology and Medicine, Switzerland
- 8GOAL Global, Dublin, Ireland
- 9Sierra Leone Ministry of Health and Sanitation
Posted April 27, 2018.
Prognostic models for Ebola virus disease derived from data collected at five treatment units in Sierra Leone and Liberia: performance, external validation, and risk visualization
